Related Experiment Video
Updated: Oct 3, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor
Tracy Tzu-Ling Tang1, Donald Dowbenko, Amanda Jackson
1Department of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080, USA.
Abstract:
The activation of the AKT/protein kinase B kinases by mutation of the PTEN lipid phosphatase results in enhanced survival of a diversity of tumors. This resistance to apoptosis is partly accomplished by the inhibition of genetic programs induced by a subfamily of forkhead transcription factors including AFX. Here we describe an AFX-regulated pathway that appears to account for at least part of this apoptotic regulatory system. Cells induced to synthesize an active form of AFX die by activating the apoptotic death pathway. An analysis of genes regulated by AFX demonstrated that BCL-6, a transcriptional repressor, is up-regulated approximately 4-7-fold. An examination of the BCL-6 promoter demonstrated that AFX bound to specific target sites that could activate transcription. BCL-X(L), an anti-apoptotic protein, contains potential BCL-6 target sites in its promoter. An analysis of endogenous BCL-X(L) levels in AFX-expressing cells revealed enhanced down-regulation of the transcript ( approximately 1.3-1.7-fold) and protein, and BCL-6 directly binds to and suppresses the BCL-X(L) promoter. Finally, macrophages isolated from BCL-6-/- mice show enhanced survival in vitro. These results suggest that AFX regulates apoptosis in part by suppressing the levels of anti-apoptotic BCL-XL through the transcriptional repressor BCL-6.
Insights
Forkhead transcription factor AFX triggers apoptosis by up-regulating BCL-6, a repressor that suppresses anti-apoptotic BCL-XL. This pathway contributes to tumor survival and apoptotic resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Mutations in PTEN activate AKT/protein kinase B, promoting tumor cell survival by inhibiting apoptosis.
- Forkhead transcription factors, including AFX, are involved in regulating apoptosis and can be inhibited by AKT signaling.
Purpose of the Study:
- To elucidate the AFX-regulated pathway involved in apoptosis.
- To investigate the role of AFX in regulating the expression of apoptosis-related genes, specifically BCL-6 and BCL-XL.
Main Methods:
- Analysis of gene expression in AFX-expressing cells.
- Chromatin immunoprecipitation assays to determine transcription factor binding.
- Reporter assays to assess transcriptional activation/repression.
- Western blotting and quantitative PCR to measure protein and transcript levels.
- Macrophage survival assays in BCL-6 knockout mice.
Main Results:
- AFX expression induces apoptosis and up-regulates the transcriptional repressor BCL-6.
- AFX directly binds to and activates the BCL-6 promoter.
- BCL-6 represses the expression of the anti-apoptotic protein BCL-XL.
- Macrophages from BCL-6 knockout mice exhibit enhanced survival.
Conclusions:
- AFX regulates apoptosis partly by suppressing BCL-XL levels via BCL-6.
- This AFX-BCL-6-BCL-XL axis represents a novel mechanism in apoptotic regulation within tumors.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Restarting Stalled Replication Forks
Cellular Injury V: Apoptosis and Autophagy
Caspases

